Stay updated on Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Sign up to get notified when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.

Latest updates to the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page
- Check2 days agoChange DetectedA minor software revision was applied, updating the page metadata from Revision: v3.6.5 to Revision: v3.6.6. The update does not alter study content or visible functionality.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating a site version update. No user-visible changes to study details or navigation are evident.SummaryDifference0.1%

- Check37 days agoChange DetectedThe page revision tag changed from v3.6.3 to v3.6.4, indicating a minor update to the ClinicalTrials.gov page.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a minor maintenance/update to the site rather than a change to the study information.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page revision tag was updated to v3.6.2, replacing the previous v3.6.0, indicating a minor page update. This change does not alter study details, eligibility criteria, or results.SummaryDifference0.1%

- Check80 days agoChange DetectedThe page now shows a recruitment status update indicating the study is no longer enrolling. New navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, and a formatting change to the Intervention/Treatment heading plus a revision tag update (v3.6.0) were applied.SummaryDifference0.5%

Stay in the know with updates to Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.